These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1684335)

  • 1. The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain.
    Stern S; Herr W
    Genes Dev; 1991 Dec; 5(12B):2555-66. PubMed ID: 1684335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain.
    Lai JS; Cleary MA; Herr W
    Genes Dev; 1992 Nov; 6(11):2058-65. PubMed ID: 1358756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV alpha-trans-activator protein.
    Kristie TM; Sharp PA
    Genes Dev; 1990 Dec; 4(12B):2383-96. PubMed ID: 1980658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment.
    Cleary MA; Stern S; Tanaka M; Herr W
    Genes Dev; 1993 Jan; 7(1):72-83. PubMed ID: 8422989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of the surface of a homeo domain protein.
    Pomerantz JL; Kristie TM; Sharp PA
    Genes Dev; 1992 Nov; 6(11):2047-57. PubMed ID: 1358755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA.
    Lai JS; Herr W
    Mol Cell Biol; 1997 Jul; 17(7):3937-46. PubMed ID: 9199328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain.
    Cleary MA; Herr W
    Mol Cell Biol; 1995 Apr; 15(4):2090-100. PubMed ID: 7891704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA recognition by the herpes simplex virus transactivator VP16: a novel DNA-binding structure.
    Babb R; Huang CC; Aufiero DJ; Herr W
    Mol Cell Biol; 2001 Jul; 21(14):4700-12. PubMed ID: 11416146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein interactions in the herpes simplex virus type 1 VP16-induced complex: VP16 peptide inhibition and mutational analysis of host cell factor requirements.
    Simmen KA; Newell A; Robinson M; Mills JS; Canning G; Handa R; Parkes K; Borkakoti N; Jupp R
    J Virol; 1997 May; 71(5):3886-94. PubMed ID: 9094665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
    Popova B; Bilan P; Xiao P; Faught M; Capone JP
    Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
    Babb R; Cleary MA; Herr W
    Mol Cell Biol; 1997 Dec; 17(12):7295-305. PubMed ID: 9372961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The herpesvirus transactivator VP16 mimics a human basic domain leucine zipper protein, luman, in its interaction with HCF.
    Lu R; Yang P; Padmakumar S; Misra V
    J Virol; 1998 Aug; 72(8):6291-7. PubMed ID: 9658067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with the assembly of a virus-host transcription complex by peptide competition.
    Haigh A; Greaves R; O'Hare P
    Nature; 1990 Mar; 344(6263):257-9. PubMed ID: 2156166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides.
    Wu TJ; Monokian G; Mark DF; Wobbe CR
    Mol Cell Biol; 1994 May; 14(5):3484-93. PubMed ID: 8164693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in determinants required for complex formation and transactivation in related VP16 proteins.
    Grapes M; O'Hare P
    J Virol; 2000 Nov; 74(21):10112-21. PubMed ID: 11024140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative regulation at the herpes simplex virus ICP4 and ICP0 TAATGARAT motifs.
    Douville P; Hagmann M; Georgiev O; Schaffner W
    Virology; 1995 Feb; 207(1):107-16. PubMed ID: 7871718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16.
    Stern S; Tanaka M; Herr W
    Nature; 1989 Oct; 341(6243):624-30. PubMed ID: 2571937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch.
    Wysocka J; Herr W
    Trends Biochem Sci; 2003 Jun; 28(6):294-304. PubMed ID: 12826401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerted activity of host cell factor subregions in promoting stable VP16 complex assembly and preventing interference by the acidic activation domain.
    LaBoissière S; Walker S; O'Hare P
    Mol Cell Biol; 1997 Dec; 17(12):7108-18. PubMed ID: 9372942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substitutions in the herpes simplex virus transactivator VP16 uncouple direct protein-protein interaction and DNA binding from complex assembly and transactivation.
    Shaw P; Knez J; Capone JP
    J Biol Chem; 1995 Dec; 270(48):29030-7. PubMed ID: 7499437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.